Haleos Labs Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by TV Praveen, was filed 07 Mar 2026.
Haleos Labs Limited: what insiders have been doing
Haleos Labs Limited belongs to the Health Care sector. Filings by its managers are published through SEBI (PIT + SAST). Between 8 November 2025 and 8 November 2026, 1 insider published 3 filings.
The flow runs one way only: 1 insider bought (3 purchases totalling €262k) and nobody sold on the market. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 1 major shareholder. One trade stands out by size: a purchase of €127k from TV Praveen, disclosed on 25 December 2025.
For context, the typical company on the same exchange (median of 1,987 companies) published 4 filings over the same period, against 3 filings here. Our records for Haleos Labs Limited go back to 2021, with 17 purchases and 11 sales on the open market in total.
The latest purchase dates back some time: it was published 246 days ago, on 7 March 2026. Between a trade and the moment it shows up on SEBI (PIT + SAST), the median delay is 2 days. This delay matters because a trade only becomes useful information once it is public.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- +21.1%Entry ₹1,278.40 · Close 14 Oct 2026 ₹1,548.40
- +1.5%Entry ₹625.50 · Close at T+365 ₹634.90
- -26.8%Entry ₹715.25 · Close at T+365 ₹523.85
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 9,400 shares@ ₹1,300.000.27% mcap5.0% of flowEquity SharesSEBI:160e4eface3eb2f7982164b531e45d7d3b16b854Canonical exit: 3 Jun 2026 (T+90)
- 1,787 shares@ ₹1,250.13990.9% of flowEquity SharesSEBI:0d3e271a77ed831dac7dd899815f53b80d1002bbCanonical exit: 26 Mar 2026 (T+90)
- 10,000 shares@ ₹1,336.605.6% of flowEquity SharesSEBI:b62a7268ddc07944c69f6b5944542780219c2109Canonical exit: 24 Mar 2026 (T+90)
- 120,595 shares@ ₹1,062.1584.3% of flowEquity SharesSEBI:3f67b44f0e8c9968e869cf91d46f0b5975c583d1
- 241,190 shares@ ₹1,062.1596.5% of flowEquity SharesSEBI:58fada8b17ad66b65911efe15d4f0c2878dd2565
- 120,595 shares@ ₹1,062.1559.3% of flowEquity SharesSEBI:d7a8d19617490d52468bd8c0272cb1ad532bb18e
- 6,367 shares@ ₹826.80432.6% of flowEquity SharesSEBI:3ee736a94e5dec9e2f85f5620d3bfe876508d303Canonical exit: 25 Sept 2024 (T+90)
- 3,101 shares@ ₹713.963251.1% of flowEquity SharesSEBI:d8e9bdbbd4bf18106c5ac828a71a1a62115e3da0
- 15,443 shares@ ₹645.30954.8% of flowEquity SharesSEBI:431744f99ceff4a7fac2318cb574b2723f7f471cCanonical exit: 25 Jun 2024 (T+90)
- 10,949 shares@ ₹541.3282.8% of flowEquity SharesSEBI:ea45387b123cd263d156acf3757633bdd0c66916Canonical exit: 27 Mar 2024 (T+90)
- 8,119 shares@ ₹516.93562.9% of flowEquity SharesSEBI:57b24a31cea61eb165f49224af26003d27062053
- 8,119 shares@ ₹516.93562.0% of flowEquity SharesSEBI:80b3c78a2a5da3635f68c6b2392f39e58393141f
- 27,428 shares@ ₹521.4037.9% of flowEquity SharesSEBI:414b9556ea496bd90649be08d0d96a96ec64131e
- 45,092 shares@ ₹517.7062.1% of flowEquity SharesSEBI:9152c6ce5b060639032943d25fded3e81d3d9f7b
- 2,457 shares@ ₹549.450512.7% of flowEquity SharesSEBI:f91a0532a961b1556a497cd8268ab1d763e10101
- 5,169 shares@ ₹611.917229.6% of flowEquity SharesSEBI:fac5c6260adc92f4f4796c737da5941f441fea01
- 14,000 shares@ ₹616.503.5% of flowEquity SharesSEBI:4d2c01de7d8e1c3fee4442ec07727cb9284bab3dCanonical exit: 26 Mar 2023 (T+90)
- 2,008 shares@ ₹669.32271.0% of flowEquity SharesSEBI:e3b7838e30136d1efaf46af419cad3256f6d50c9Canonical exit: 20 Sept 2022 (T+90)
- 10,350 shares@ ₹719.51695.7% of flowEquity SharesSEBI:97356b900e0ea6b9a47303c48ea58bd6dfb09bbdCanonical exit: 18 Sept 2022 (T+90)
- 23,291 shares@ ₹704.73578.8% of flowEquity SharesSEBI:ed3a4aece2fe6f1ec0dcbd12f906d0f7592c153eCanonical exit: 18 Sept 2022 (T+90)
- 2,546 shares@ ₹691.67321.3% of flowEquity SharesSEBI:4d16a0d10f1b4f551be42099c79634ac1c5189f9Canonical exit: 7 Sept 2022 (T+90)
- 562 shares@ ₹782.918111.2% of flowEquity SharesSEBI:bf14d69df4e2ab6685676a9da4017935686f7104Canonical exit: 7 Jul 2022 (T+90)
- 6,852 shares@ ₹699.5038100.0% of flowEquity SharesSEBI:081b05a798a74cca58c9f02162726a35b288cb46Canonical exit: 29 Jun 2022 (T+90)
- 2,679 shares@ ₹674.87871.3% of flowEquity SharesSEBI:c9dbcdf3039db47b47d23e59b7c929daee3f3a54Canonical exit: 29 May 2022 (T+90)
- 6,594 shares@ ₹734.28073.6% of flowEquity SharesSEBI:74ab737a263fa383a64b20494047e7e19f5e0536Canonical exit: 25 May 2022 (T+90)
25 of 37 declarations
About Haleos Labs Limited
Haleos Labs Limited is a company specializing in the health and pharmaceutical sector. It is listed on the XBOM.
